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 Recently, new strategies emerged in the field of monoclonal antibodies radiolabeling for PET 
imaging with the use of positron emitter such as zirconium-89 or gallium-68[1]. Despite their important 
role in the therapeutic world, antibodies have many disadvantages related to their structure. Moreover, 
conjugation of chelating agent often occurs on lysines, which is non-regioselective and leads to a 
heterogeneous mixture of products. In addition, the slow clearance of antibodies can be a problem to 
obtain a good contrast when they are used in imaging.  
 To address these different limitations, we developed a chemistry-free chelating system consisting 
of a highly phosphorylatable peptide tag. A specific phosphorylation step, with the alpha subunit of 
the casein kinase II (CKIIα), can generate a nanocluster of four phosphates that can interact strongly 
with metal ions like zirconium[2]. 
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Small Protein: 10kDa  
   (rapid clearance) 
pH stability:  0-12 
Temperature  Tm≈80°C 
Stability: 
Production  Low (Generated in vitro and  
cost:   produced in bacteria) 
Affinity:   0,1nM 
DEVELOPMENT OF AN IN VIVO CO-EXPRESSION AND 
PHOSPHORYLATION SYSTEM 




 In parallel to the development of the in vivo system, we are developing a phosphoprotein purification protocol by immobilized metal affinity chromatography, 
relying on the specific interaction of phosphate moeity with gallium(III) or iron(III). The use of a single tag for both the purification and the labeling will provide a 
much simpler and straightforward system. Finally this fusion system of phosphate nanocluster and a Nanofitin® will allows us to combine the advantages of an original 
single step regioselective labeling for both zirconium-89 and gallium-68, together with a highly stable targeting moiety. Concerning the chelation experiments, we have 
planned to realize a fluorescence studies with peptide-gallium complex and phospho-Nanofitin. Depending of those results, we will optimize the sequence of the tag to 
obtain an high affinity. 
CONCLUSION  
  1) Adapt the labeling tag to the stereoselective chelation of radionuclides for PET imaging. 
  2) Genetically fuse the tag to a Nanofitin, a protein scaffold developed as an alternative to     
   antibodies, to ensure an efficient targeting of the radionuclide.  
OBJECTIVES: 
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Equivalent of terbium per peptide 
Terbium(III) titration of mono- and tetra-
phosphorylated peptides in formic acid pH2 





























Equivalent of terbium or terbium/zirconium (1:1) per peptide 
 
Terbium(III) titration of tri-phosphorylated 
peptide and competition with zirconium(IV) 
in formic acid pH2 
(After removal of peptide and terbium fluorescence) 
Tri-phosphorylated peptide + TbCl3 Tri-phosphorylated peptide + TbCl3/ZrOCl2 (1:1) 
 
● Fluorescence increases as the peptide is phosphorylated.  
 
● Chelation of the zirconium by the peptide tag was confirmed by a 
competition study. 
In early development, the phosphorylation was realized in vitro. In order to 
save purification steps, we developed an in vivo phosphorylation system 
consisting in the co-expression of a Nanofitin® fused to the 
phosphorylatable tag (pNF) and the CKIIα. 
● Effectiveness of the in vivo system was demonstrated both by 
electrophoretic mobility shift assay and staining with a specific 
phosphoprotein staining gel: ProQDiamond®.  
 




























3P 4P 0P 
Nanofitin® (pHi 5,35) 
PhosphoNanofitin®  
 To evaluate the phosphorylation rate we developped an isoelectric 
focusing method based on the fact that the pHi of the Nanofitin® 
decreases as the protein is phosphorylated. Such a technique allowed us to 
isolate the different phosphorylation states of the phospho-
Nanofitin® (from 0 to 4 phospho-serine). 
Arabinose 0.2% 
IPTG 0.5mM 











To optimize the sequence of the phosphorylatable tag, we studied the 
chelation of different mimetic peptides with a lanthanide (terbium).  
